LIGABUE, Giulia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.829
NA - Nord America 6.697
AS - Asia 4.262
SA - Sud America 565
AF - Africa 121
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 4
Totale 19.492
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.534
IT - Italia 4.593
SG - Singapore 1.307
CN - Cina 1.215
DE - Germania 809
GB - Regno Unito 765
VN - Vietnam 506
HK - Hong Kong 471
BR - Brasile 414
SE - Svezia 373
RU - Federazione Russa 280
NL - Olanda 206
FR - Francia 197
FI - Finlandia 172
KR - Corea 149
IN - India 112
TR - Turchia 92
CA - Canada 85
UA - Ucraina 84
ID - Indonesia 83
AR - Argentina 57
BD - Bangladesh 54
BG - Bulgaria 53
MX - Messico 52
JP - Giappone 46
ES - Italia 44
IQ - Iraq 36
ZA - Sudafrica 32
PL - Polonia 31
CH - Svizzera 28
PK - Pakistan 27
MA - Marocco 26
BE - Belgio 22
CZ - Repubblica Ceca 22
AT - Austria 19
IE - Irlanda 19
IR - Iran 19
MY - Malesia 19
EC - Ecuador 18
VE - Venezuela 18
LT - Lituania 16
CL - Cile 15
CO - Colombia 15
AE - Emirati Arabi Uniti 14
PT - Portogallo 13
UZ - Uzbekistan 13
AU - Australia 12
PE - Perù 12
AZ - Azerbaigian 11
DZ - Algeria 11
EG - Egitto 11
IL - Israele 11
RO - Romania 11
KE - Kenya 10
TW - Taiwan 10
AL - Albania 9
PH - Filippine 9
PY - Paraguay 9
SA - Arabia Saudita 9
TN - Tunisia 9
DK - Danimarca 8
JO - Giordania 8
MT - Malta 8
SI - Slovenia 8
BY - Bielorussia 7
CR - Costa Rica 7
DO - Repubblica Dominicana 7
KZ - Kazakistan 7
NO - Norvegia 6
NP - Nepal 6
PA - Panama 6
NG - Nigeria 5
RS - Serbia 5
GR - Grecia 4
HR - Croazia 4
MD - Moldavia 4
OM - Oman 4
BO - Bolivia 3
GE - Georgia 3
KH - Cambogia 3
TH - Thailandia 3
UY - Uruguay 3
BH - Bahrain 2
EU - Europa 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
MC - Monaco 2
MK - Macedonia 2
MZ - Mozambico 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BI - Burundi 1
Totale 19.468
Salva come PNG Salva come JPEG
Città #
Singapore 847
Ashburn 758
Santa Clara 737
Fairfield 548
Southend 459
Hong Kong 455
Hefei 428
San Jose 413
Milan 412
Chandler 392
Rome 318
Woodbridge 289
Houston 253
Seattle 211
Cambridge 204
Wilmington 202
Beijing 193
Nyköping 187
Ann Arbor 168
London 164
Ho Chi Minh City 159
Seoul 139
Jacksonville 138
Naples 136
Dearborn 132
Council Bluffs 126
Hanoi 124
Modena 117
Helsinki 116
Los Angeles 115
The Dalles 89
Bologna 86
New York 85
Munich 73
Dallas 69
Turin 67
Bari 66
Florence 65
Frankfurt am Main 62
Lauterbourg 62
Moscow 53
Jakarta 52
Chicago 50
Parma 48
São Paulo 48
Princeton 47
Sofia 47
San Diego 46
Shanghai 42
Catania 41
Orem 41
Izmir 39
Buffalo 38
Palermo 35
Tokyo 34
Genoa 33
Eugene 32
Fremont 32
Nuremberg 30
Verona 30
Brescia 29
Des Moines 29
Redwood City 29
Reggio Emilia 27
Padova 25
Falls Church 23
Guangzhou 23
Warsaw 23
Montreal 22
Da Nang 21
Kent 21
Phoenix 21
Salerno 21
Toronto 21
Atlanta 20
Cagliari 20
Livorno 20
Lucca 20
Turku 20
Denver 18
Durham 18
Monza 18
Salt Lake City 18
Amsterdam 17
Bremen 17
Venice 17
Baghdad 16
Brussels 16
Haiphong 16
Poplar 16
Chennai 15
Mexico City 15
Perugia 15
Wuhan 15
Boardman 14
Columbus 14
Dublin 14
Norwalk 14
Rio de Janeiro 14
Brooklyn 13
Totale 11.247
Salva come PNG Salva come JPEG
Nome #
Effetto della N-acetilcisteina sulla progressione dell'insufficienza renale cronica nel ratto 4.248
Clinical outcome of kidney transplantation in HIV-infected recipients: a retrospective study 421
CD133 and CD24 expression in renal tissue of patients affected by autosomal dominant polcystic kidney disease 397
Interstitial fluid obtained from kidney biopsy as new source of renal biomarkers 379
Evaluation of a system for sorbent-assisted peritoneal dialysis in a uremic pig model 366
Identification and Characterization of New Proteins in Podocyte Dysfunction of Membranous Nephropathy by Proteomic Analysis of Renal Biopsy 357
The prevalence of autosomal dominant polycystic kidney disease (ADPKD): A meta-analysis of European literature and prevalence evaluation in the Italian province of Modena suggest that ADPKD is a rare and underdiagnosed condition 351
P-Cresol and Cardiovascular Risk in Kidney Transplant Recipients 343
GREASE II. A phase II randomized, 12-month, parallel-group, superiority study to evaluate the efficacy of a Modified Atkins Diet in Autosomal Dominant Polycystic Kidney Disease patients 341
Rhodococcus equi Pneumonia in Kidney Transplant Recipient Affected by Acute Intermittent Porphyria: A Case Report 338
Confidence Calibration for Deep Renal Biopsy Immunofluorescence Image Classification 333
Evaluation of the Classification Accuracy of the Kidney Biopsy Direct Immunofluorescence through Convolutional Neural Networks 328
Identification and characterization of a new autoimmune protein in membranous nephropathy by immunoscreening of a renal cDNA library 326
Immunophenotypic Profile and Clinical Outcome of Monoclonal B-cell Lymphocytosis in Kidney Transplantation 321
Activation of coagulation during hemodialysis: Effect of blood lines alone and whole extracorporeal circuit 316
Automated Prediction of Kidney Failure in IgA Nephropathy with Deep Learning from Biopsy Images 313
A functionally active RAR alpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines 307
Efficacy of Belimumab for active lupus nephritis in a young Hispanic woman intolerant to standard treatment: a case report 304
I polimorfismi del gene dell’enzima di conversione dell’angiotensina (ACE) nel rene policistico autosomico dominante (ADPKD) 286
[Dyslipidemia and the risk of kidney disease]. 279
Il rene policistico autosomico dominante (ADPKD): aspetti genetico-molecolari, clinici ed epidemiologici nella provincia di Modena. 276
Relapse of atypical hemolytic uremic syndrome during pregnancy in a patient on eculizumab maintenance treatment: A case report 269
Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease 268
Water treatment and monitor disinfection 265
The Role of PEC Progenitors in ADPKD Progression 260
A validated model of disease progression in IgA nephropathy 257
Acid base disorders in patients with COVID-19 257
Proteomic analysis of urine from proteinuric patients shows a proteolitic activity directed against albumin 251
In vitro efficacy and safety of a system for sorbent-assisted peritoneal dialysis 248
Detection of predictive urinary biomarkers of nephropathy in type 1 and type 2 diabetes by proteomic analysis 244
#5187 GREASE II: A PHASE II RANDOMIZED, 24-MONTH, PARALLEL-GROUP, SUPERIORITY STUDY TO EVALUATE THE EFFICACY OF A KETOGENIC DIET IN ADPKD PATIENTS 243
Epidermal growth factor receptor polymorphism and autosomal dominant polycystic kidney disease 243
Interstitiome: a novel proteomic discipline applied to renal biopsy 233
Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19 233
FP808EARLY IDENTIFICATION OF SICKLE CELL NEPHROPATHY IN A COHORT OF CHILDREN WITH SICKLE CELL DISEASE 232
COVID-19 Rapid Antigen Test Screening in Patients on Hemodialysis 230
Post-transplant recurrence of glomerulonephritis: a complex clinical case. 230
Screening of a kidney cDNA library for the identification of autoimmune proteins from serum of membranous nephropathy patients. 227
Screening of a kidney cDNA library for the identification of autoimmune proteins from serum of membranous nephropathy patients. 227
P-cresolo solfato e rischio cardiovascolare nel paziente trapiantato 224
The underlying cause of kidney disease is often unknown in dialysis patients: a possible genomic approach 217
Combining telemedicine and in-person visits to deliver care to patients with severe chronic kidney disease (CKD): Lessons learned from COVID-19 209
Clinical Predictors of Nondiabetic Kidney Disease in Patients with Diabetes: A Single-Center Study 205
Influence of dialysate temperature on creatinine peritoneal clearance in peritoneal dialysis patients: a randomized trial 197
Immunosuppressive therapy reduction and early post-infection graft function in kidney transplant recipients with COVID-19 184
AKI in hospitalized patients with COVID-19: a single-center experience 181
Risk of bleeding after percutaneous native kidney biopsy in patients receiving low-dose aspirin: a single-center retrospective study 174
Risk of infections related to endovascular catheters and cardiac implantable devices in hemodialysis patients 172
Reversed high-flux SUPRA HFR: a proof of concept pilot study to access the middle molecular weight uremic toxins 172
Weekly Rapid Antigen Test Screening for COVID-19 in Patients on Hemodialysis 168
Prolonged RT-PCR test positivity in hemodialysis patients with COVID-19 157
Rethinking Chronic Kidney Disease in the Aging Population 156
Towards the monitoring of dialysis treatment through absorption and endogenous fluorescence techniques 147
Seroconversion after COVID-19 vaccine in a dialysis patient on immunosuppressants 144
Il centro dialisi ecosostenibile 133
Rationale and design of the CORDIAL first-in-human clinical trial: a system for sorbent-assisted continuous flow peritoneal dialysis 125
Screening for nasal carriage of Staphylococcus (S.) aureus reduces the risk of S. aureus peritonitis in patients on peritoneal dialysis (PD) 125
Reactogenicity of COVID-19 vaccine in hemodialysis patients: a single-center retrospective study 125
Prevalence, clinical course and outcomes of COVID-19 in peritoneal dialysis (PD) patients: a single-center experience 122
Middle-Molecular Weight Toxin Removal: Asymmetric Cellulose Triacetate vs. Helicoidal Polysulfone during Online Hemodiafiltration (CHORALS Study) 116
Migrants on hemodialysis (HD): clinical characteristics, outcome and quality of life 109
Long-term mortality and technique survival in peritoneal dialysis patients: a 25-year retrospective analysis in a single center 98
Formative usability test of a novel device for peritoneal dialysis (WEAKID) 97
Diagnostic Yield and Clinical Impact of a Small Genetic Panel for Kidney Disease: A Multicenter, Retrospective European Study 88
Improving the sustainability and quality of kidney health care through life cycle assessments, quality improvement, education and technical innovations: the KitNewCare approach 82
Validation of Hemoglobin and Hematocrit Measurements from a Dialysis Machine Sensor Compared to Laboratory Analysis: A Cross-Sectional Study 80
A life cycle assessment of peritoneal dialysis procurement in Italy: environmental burden and opportunities for improvement 61
Intradialytic clearances and reduction ratios for middle molecular weight uremic toxins and protein-bound uremic toxins: comparison of hemodiafiltration with asymmetric cellulose triacetate vs hemodiafiltration with helycoidal polysulfone during a 6-month follow-up 33
Rationale and design of the CORDIAL first-in-human clinical trial: A system for sorbent-assisted continuous flow peritoneal dialysis 31
#2314 Greenhouse gas emissions from the special waste incineration: a comparative analysis between a large Dialysis Center and a University Hospital 25
Assessing middle-molecular and protein-bound uremic toxins: a six month study of ATA vs PS membranes in hemodiafiltration 25
Sustainable kidney care: A life cycle assessment of the peritoneal dialysis pathways 23
Green haemodialysis: comparison of dialysis bags versus fresenius granumix at the AOU Policlinico di Modena, Italy 22
Theoretically redesigning peritoneal dialysis products for sustainability: A life cycle inventory approach 22
Twelve-Month Evaluation of Middle Molecule (MMUT) and Protein-Bound Uremic Toxin (PBUT) Removal with Two Different Hemodiafiltration Filters 20
Comparing environmental footprints of haemodialysis and online haemodiafiltration in Italy 17
Totale 19.633
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.920
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.920
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021371 0 0 0 0 0 0 0 0 0 196 117 58
2021/20221.117 71 93 65 110 50 98 53 54 107 77 213 126
2022/20231.981 126 173 94 171 168 274 136 216 189 113 179 142
2023/20242.501 111 118 200 244 291 246 302 255 119 181 201 233
2024/20254.429 245 232 230 345 624 605 401 281 435 202 375 454
2025/20265.696 454 295 498 694 828 383 864 334 680 666 0 0
Totale 19.633